Center Partners

Dawn E. Sugarman, PhD

Assistant Professor in the Department of Psychiatry at Harvard Medical School; Assistant psychologist at McLean Hospital in the Division of Alcohol, Drugs, and Addiction

Digital Therapeutics; Gender Differences; Comorbidity

Contact

Dawn E. Sugarman, PhD
Assistant Professor in the Department of Psychiatry at Harvard Medical School; Assistant psychologist at McLean Hospital in the Division of Alcohol, Drugs, and Addiction

McLean Hospital, 115 Mill Street, Belmont MA

dsugarman@mclean.harvard.edu


Dr. Sugarman received her PhD from Syracuse University and completed predoctoral and post-doctoral fellowships at Yale School of Medicine. Her research primarily focuses on the use of technology in increasing access to evidence-based treatments for substance use disorders, with an emphasis on special populations such as women and individuals with substance use and co-occurring other psychiatric disorders. Dr. Sugarman was the inaugural recipient of the Sarles Young Investigator Award for Research on Women and Addiction at McLean Hospital. She is the current recipient of a NIDA-funded K23 award focused on increasing women’s engagement in medication treatment for opioid use disorder through digital intervention. Dr. Sugarman also serves as the Communications Editor for the Harvard Review of Psychiatry.

In her free time, Dr. Sugarman enjoys travel, hiking with her husband and two sons, and listening to live music.


Selected Publications
  • type-published
    1588291200
    5
    2020
    Sugarman DE, Meyer LE, Reilly ME, Greenfield SF. Feasibility and acceptability of a web-based, gender-specific intervention for women with substance use disorders. J Womens Health (Larchmt). 2020 May;29(5):636-646. doi: 10.1089/jwh.2018.7519. PMID: 31584313.
    View Source
  • type-published
    1543622400
    12
    2018
    McHugh RK, Votaw VR, Sugarman DE, Greenfield SF. Sex and gender differences in substance use disorders. Clin Psychol Rev. 2018 Dec;66:12-23. doi: 10.1016/j.cpr.2017.10.012. PMID: 29174306; PMCID: PMC5945349.
    View Source
  • type-published
    1512086400
    12
    2017
    Sugarman DE, Reilly ME, Greenfield SF. Treatment outcomes for women with substance use disorders: A critical review of the literature (2010–2016). Curr Addict Rep. 2017 December;4;482–502. https://doi.org/10.1007/s40429-017-0172-9.
    View Source
  • type-published
    1493596800
    5
    2017
    Sugarman DE, Campbell ANC, Iles BR, Greenfield SF. Technology-based interventions for substance use and comorbid disorders: An examination of the emerging literature. Harv Rev Psychiatry. 2017 May/Jun;25(3):123-134. doi: 10.1097/HRP.0000000000000148. PMID: 28475504; PMCID: PMC5421396.
    View Source
  • type-published
    1422057600
    1
    2015
    Campbell AN, Nunes EV, Pavlicova M, Hatch-Maillette M, Hu MC, Bailey GL, Sugarman DE, Miele GM, Rieckmann T, Shores-Wilson K, Turrigiano E, Greenfield SF. Gender-based outcomes and acceptability of a computer-assisted psychosocial intervention for substance use disorders. J Subst Abuse Treat. 2015;53:9-15. PMID: 25613105; PMCID: PMC4414709.
    View Source